| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 15 | 31 | 37 | 34 | 31 | 28 | 27 | 27 | 20 | 30 | 25 | 26 | 27 | 28 | 30 | 40 | 29 | 34 | 35 |
| Expenses | 14 | 26 | 31 | 28 | 25 | 25 | 25 | 25 | 20 | 28 | 25 | 25 | 26 | 27 | 29 | 27 | 26 | 31 | 32 |
| EBITDA | 1 | 5 | 6 | 7 | 6 | 3 | 1 | 3 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 13 | 2 | 3 | 3 |
| Operating Profit % | 3 % | 15 % | 16 % | 18 % | 15 % | 7 % | 0 % | 6 % | -1 % | 6 % | -1 % | 1 % | 1 % | 3 % | 3 % | 7 % | 5 % | 9 % | 9 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 3 | 5 | 5 | 5 | 1 | -0 | 0 | -2 | 1 | -1 | -1 | -1 | -0 | -1 | 11 | 1 | 2 | 2 |
| Tax | 0 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 0 | 1 | 0 | 1 | 1 |
| Net Profit | -1 | 2 | 4 | 4 | 4 | 1 | -1 | 0 | -2 | 0 | -2 | -1 | -1 | -1 | -1 | 10 | 0 | 2 | 1 |
| EPS in ₹ | -2.24 | 0.45 | 3.69 | 3.54 | 4.13 | -1.24 | -2.82 | -1.00 | -3.65 | -0.43 | -3.55 | -2.27 | -2.61 | -2.18 | -1.67 | 14.94 | -0.50 | -0.08 | 0.74 |
Makers Laboratories
Makers Laboratories
136.50
+6.50
(5.00%)
Market Cap
76.70 Cr
EPS
12.70
PE Ratio
9.14
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
230.00
52 Week Low
122.00
PB Ratio
1.14
Debt to Equity
0.22
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Makers Laboratories Reports Strong Q1 Growth with 18.3% Revenue Rise and Return to Profitability
Aug 11, 2025
Aug 11, 2025Makers Laboratories Ltd reported mixed financial results for Q1 FY2026 ended June 30, 2025. Total income from operations increased 18.3% year-on-year to Rs. 3,500.10 lakhs from Rs. 2,959.17 lakhs. The company returned to profitability with net profit after tax of Rs. 128.61 lakhs compared to a loss of Rs. 70.39 lakhs in the same period last year. Net profit before tax rose significantly to Rs. 197.63 lakhs from Rs. 41.96 lakhs. Profit margins improved substantially, with net profit before tax margin reaching 5.6% versus 1.4% previously, and net profit after tax margin turning positive at 3.7% from negative 2.4%. Earnings per share was Rs. 0.74 compared to a loss per share of Rs. 1.67 in Q1 FY2025. However, on a standalone basis, the company still reported a loss before tax of Rs. 29.95 lakhs, though this was an improvement from the Rs. 123.54 lakhs loss in the previous year. Equity share capital remained unchanged at Rs. 590.04 lakhs.
Makers Laboratories Re-appoints Vishal Jain as Independent Director for Second Five-Year TermAug 08, 2025
Makers Laboratories Ltd shareholders approved the re-appointment of Vishal Jain as Independent Director for a second consecutive five-year term from November 4, 2025 to November 3, 2030. The approval was granted at the company's 40th Annual General Meeting held on August 8, 2025 through a special resolution. Jain, aged 49, holds a commerce graduate degree and MBA from SP Jain Institute of Management, with additional finance coursework from London Business School. He is an entrepreneur with experience in manufacturing plastic household goods and ROPP closures. The company confirmed that Jain is not related to any other directors or key managerial personnel.
Makers Laboratories Reports Mixed Q1 FY2026 Results with Standalone Loss and Consolidated ProfitAug 08, 2025
Aug 08, 2025Makers Laboratories Ltd announced its quarterly results for the period ended June 30, 2025. On a standalone basis, the company reported a net loss of Rs 121.89 lacs compared to a profit of Rs 464.11 lacs in the same quarter last year. Revenue from operations declined to Rs 970.07 lacs from Rs 1,228.95 lacs year-over-year. However, on a consolidated basis, the company posted a net profit of Rs 43.67 lacs versus a loss of Rs 98.46 lacs in the previous year quarter. Consolidated revenue from operations decreased to Rs 2,959.17 lacs from Rs 3,500.10 lacs. The company operates in pharmaceutical and chemical manufacturing segments through its subsidiary Resonance Specialties Limited. Earnings per share on a standalone basis was negative Rs 2.07 compared to positive Rs 7.87 in the corresponding quarter last year.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,636.20 | #1 3,82,526.00 | 34.22 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 43.29 | |
5,710.00 | 1,51,038.30 | 65.74 | 9,712.00 | 18.67 | 2,191 | 26.74 | 28.97 | |
3,567.10 | 1,21,948.70 | 59.71 | 11,539.40 | 6.99 | 1,911 | 19.91 | 51.91 | |
1,513.00 | 1,21,429.70 | 22.68 | 28,409.50 | 7.12 | 5,291 | 9.88 | 39.80 | |
1,244.70 | 1,02,131.70 | #1 18.31 | 33,741.20 | 16.73 | 5,725 | 1.26 | 34.86 | |
2,439.60 | 1,00,535.60 | 53.25 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 34.79 | |
991.15 | 98,802.10 | 21.41 | 23,511.00 | 18.55 | 4,615 | 2.60 | 40.31 | |
1,981.30 | 87,299.50 | 24.47 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 38.96 | |
5,459.50 | 64,864.00 | 28.71 | 13,458.30 | 3.70 | 2,216 | 21.39 | 52.88 | |
1,086.00 | 62,953.10 | 18.78 | 32,345.60 | 9.43 | 3,484 | -10.24 | 49.39 |
Forecast
Actual
Growth Rate
Revenue Growth
25.21 %
Net Income Growth
-327.08 %
Cash Flow Change
-585.71 %
ROE
-305.42 %
ROCE
-833.54 %
EBITDA Margin (Avg.)
526.23 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 136 | 144 | 152 | 161 | 148 |
| Fixed Assets | 71 | 68 | 85 | 87 | 74 |
| Current Assets | 61 | 63 | 63 | 70 | 68 |
| Capital Work in Progress | 0 | 9 | 1 | 0 | 1 |
| Investments | 2 | 0 | 0 | 3 | 0 |
| Other Assets | 63 | 66 | 67 | 71 | 73 |
| Total Liabilities | 136 | 144 | 152 | 161 | 148 |
| Current Liabilities | 33 | 33 | 28 | 37 | 21 |
| Non Current Liabilities | 17 | 13 | 15 | 20 | 12 |
| Total Equity | 87 | 98 | 110 | 104 | 115 |
| Reserve & Surplus | 49 | 55 | 63 | 57 | 65 |
| Share Capital | 5 | 5 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -3 | -2 | -0 | -0 |
| Investing Activities | 0 | -22 | 1 | -7 | 20 |
| Operating Activities | 0 | 19 | -9 | 1 | -4 |
| Financing Activities | 0 | 0 | 6 | 6 | -16 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 58.37 % | 58.37 % | 58.37 % | 58.37 % | 58.37 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % | 61.27 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.39 % | 0.39 % | 0.00 % | 0.39 % | 0.39 % | 0.00 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % | 0.39 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.49 % | 29.45 % | 29.28 % | 30.60 % | 31.62 % | 29.57 % | 29.96 % | 29.98 % | 29.80 % | 29.73 % | 29.63 % | 29.65 % | 29.93 % | 30.54 % | 30.86 % | 30.67 % | 30.90 % | 31.01 % |
| Others | 12.14 % | 12.18 % | 12.35 % | 11.03 % | 10.01 % | 9.15 % | 8.38 % | 8.36 % | 8.93 % | 8.61 % | 8.70 % | 9.08 % | 8.40 % | 7.80 % | 7.48 % | 7.67 % | 7.43 % | 7.33 % |
| No of Share Holders | 3,914 | 3,943 | 3,937 | 4,075 | 4,667 | 4,753 | 4,839 | 4,621 | 4,483 | 4,402 | 4,283 | 4,179 | 4,176 | 4,090 | 4,008 | 4,031 | 4,135 | 4,073 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1 | 1 | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.42 | 1.98 | 3.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Apr 2022 |  Rights | 1:5 | 30 Mar 2022 | 188.15 | 182.60 |
| 06 Aug 2024 |  Annual General Meeting | NA | 06 Aug 2024 | 133.55 | 167.75 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 151.05 | 144.15 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 183.10 | 174.75 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 135.30 | 159.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 154.00 | 155.60 |
| 08 Aug 2025 | Annual General Meeting | NA | 08 Aug 2025 | 149.75 | 155.60 |
Announcements
Closure of Trading Window6 days ago
6 days agoRelodgement Of Transfer Requests Of Physical Shares - July 2025 And August 2025Sep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Aug 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 08, 2025
Aug 08, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2025
Aug 08, 2025Standalone And Consolidated Unaudited Financial Results For Q1FY26Aug 08, 2025
Aug 08, 2025Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY26Aug 08, 2025
Aug 08, 2025Board Meeting Intimation for Standalone And Consolidated Financial Results For Q1FY26Jul 25, 2025
Jul 25, 2025Intimation To Shareholders Whose E-Mail Ids Are Not Registered With The Company / RTA / DPJul 14, 2025
Jul 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 202540Th Annual General Meeting Of The Company To Be Held On Friday 8Th August 2025Jul 09, 2025
Jul 09, 2025Reg. 34 (1) Annual Report.Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Change In The Name Of Statutory Audit FirmJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 05, 2025
Jun 05, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 26, 2025
May 26, 2025Standalone And Consolidated Q4FY25 ResultsMay 26, 2025
May 26, 2025Board Meeting Outcome for Standalone And Consolidated Q4FY25 ResultsMay 26, 2025
May 26, 2025Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For Q4 And FY25May 13, 2025
May 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2025
Jan 30, 2025Integrated Filing (Financial)Jan 29, 2025
Jan 29, 2025Standalone And Consolidated Q3FY25 Unaudited Financial ResultsJan 29, 2025
Jan 29, 2025Board Meeting Outcome for Standalone And Consolidated Q3FY25 Unaudited Financial ResultsJan 29, 2025
Jan 29, 2025Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December 2024Jan 14, 2025
Jan 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Change Of Name Of Registrar And Share Transfer Agent Of The CompanyJan 03, 2025
Jan 03, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Dec 06, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Dec 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Oct 30, 2024Standalone And Consolidated Q2H1FY25 ResultsOct 29, 2024
Oct 29, 2024Board Meeting Outcome for Standalone And Consolidated Q2H1FY25 ResultsOct 29, 2024
Oct 29, 2024Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30Th September, 2024.Oct 17, 2024
Oct 17, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Oct 08, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2024
Sep 27, 2024Closure of Trading WindowSep 24, 2024
Sep 24, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2024
Aug 07, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2024
Aug 07, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 06, 2024
Aug 06, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMAug 06, 2024
Aug 06, 2024Technical Indicators
RSI(14)
Neutral 43.44
ATR(14)
Volatile 6.94
STOCH(9,6)
Neutral 39.39
STOCH RSI(14)
Neutral 33.48
MACD(12,26)
Bearish -0.57
ADX(14)
Strong Trend 39.22
UO(9)
Bearish 51.82
ROC(12)
Downtrend And Accelerating -5.24
WillR(14)
Neutral -60.04
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
